Publication: Clinical utility of biomarkers in IBD
Clinical utility of biomarkers in IBD
Date
Date
Date
Citations
Rogler, G., & Biedermann, L. (2015). Clinical utility of biomarkers in IBD. Current Gastroenterology Reports, 17(7), 17:26. https://doi.org/10.1007/s11894-015-0449-x
Abstract
Abstract
Abstract
There is no gold standard for the diagnosis and monitoring of inflammatory bowel diseases (IBD). Biomarkers are useful tools for the management of patients suffering from IBD. However, they should be used only when their additional information is useful for clinical decision-making. In principal, four situations during the management of an individual IBD patient can be discriminated from a clinical standpoint in which biomarkers provide useful information. First, biomarkers may be helpful when the diagnosis of IBD is established and a
Metrics
Views
Additional indexing
Creators (Authors)
- Rogler, G
- Biedermann, L
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Views
Citations
Rogler, G., & Biedermann, L. (2015). Clinical utility of biomarkers in IBD. Current Gastroenterology Reports, 17(7), 17:26. https://doi.org/10.1007/s11894-015-0449-x